Anticuerpos anti-F2/3 como marcador de curacion en niños con infeccion congenita por Trypanosoma cruzi

Altcheh, Jaime; Corral, Ricardo; Biancardi, Miguel A; Freilij, Hector.
Medicina [B.Aires] ; 63(1): 37-40, 2003. ilus, graf
Artículo en Español | BINACIS | ID: bin-6609

Documentos relacionados

  1. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission.
  2. Serum Cytokines as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure.
  3. Amplicon Sequencing Reveals Complex Infection in Infants Congenitally Infected With Trypanosoma Cruzi and Informs the Dynamics of Parasite Transmission.
  4. Chagas disease in immunocompromised patients.
  5. [Anti-F2/3 antibodies as cure marker in children with congenital Trypanosoma cruzi infection].
  6. Toward Improving Early Diagnosis of Congenital Chagas Disease in an Endemic Setting.
  7. Trypomastigote Excretory Secretory Antigen Blot Is Associated With Trypanosoma cruzi Load and Detects Congenital T. cruzi Infection in Neonates, Using Anti-Shed Acute Phase Antigen Immunoglobulin M.
  8. Congenital chagas disease: Development and assessment of a specific IgM capture-based assay for diagnosis of transmission.
  9. IgG Autoantibodies Induced by T. cruzi During Pregnancy: Correlation with Gravidity Complications and Early Outcome Assessment of the Newborns.
  10. Epidemiology of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in the Americas: systematic review and meta-analysis.